Dyadic International, Inc. (DYAI)Healthcare | Biotechnology | Jupiter, United States | NasdaqCM
1.02 USD
-0.04
(-3.774%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.01 -0.01 (-0.012%) ⇩ (July 13, 2026, 7:08 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:49 a.m. EDT
The investment case for Dyadic International is currently broken by a severe structural decline in share price. Over the last nine years, the stock has lost nearly 40% of its value, and the most recent five consecutive years have seen double-digit annual declines. This relentless downward trajectory suggests the market has permanently downgraded its view of the company's ability to generate value, regardless of recent revenue bumps or partnerships. Fundamentally, the picture is dire: the company is burning cash with negative free cash flow, negative operating margins, and a negative book value. While analysts project a breakeven point, the path to profitability remains unproven, and the current price-to-sales multiple is inflated given the lack of earnings. There is no dividend to provide income, and the balance sheet offers no fortress-like protection against further dilution or operational struggles. The recent price action shows a slight technical bounce off lows, but this appears to be a dead-cat bounce rather than a reversal of the long-term downtrend. Investors should avoid this security until there is concrete evidence of sustained profitability and a halt to the multi-year price erosion. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.092149 |
| AutoETS | 0.092753 |
| MSTL | 0.102375 |
| AutoTheta | 0.108754 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 1.29 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.31 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.111 |
| Market Cap | 37,167,476 |
| Forward P/E | -3.19 |
| Beta | 1.15 |
| Profit Margins | -191.50% |
| Website | https://www.dyadic.com |
As of July 11, 2026, 3:49 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Call volume is negligible across all expirations, while put activity is concentrated in the nearest expiration (July 17) with significant new flow entering at-the-money strikes. Open interest is heavily skewed toward out-of-the-money calls at distant strikes (February 2027), suggesting speculative bets on a massive rally far in the future, but the immediate sentiment is defensive. Implied volatility is elevated relative to the low absolute prices, indicating fear of further decline.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.09278345 |
| Address1 | 1,044 North U.S. Highway One |
| Address2 | Suite 201 |
| All Time High | 10.98 |
| All Time Low | 0.05 |
| Ask | 1.27 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 270,560 |
| Average Daily Volume3 Month | 293,921 |
| Average Volume | 293,921 |
| Average Volume10Days | 270,560 |
| Beta | 1.145 |
| Bid | 0.8064 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | -0.011 |
| City | Jupiter |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.02 |
| Current Ratio | 2.418 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.15 |
| Day Low | 0.98 |
| Display Name | Dyadic |
| Earnings Call Timestamp End | 1,778,706,000 |
| Earnings Call Timestamp Start | 1,778,706,000 |
| Earnings Timestamp | 1,778,702,400 |
| Earnings Timestamp End | 1,786,564,800 |
| Earnings Timestamp Start | 1,786,564,800 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 9.615 |
| Enterprise Value | 36,612,588 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -0.21 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 561 743 8343 |
| Fifty Day Average | 0.789 |
| Fifty Day Average Change | 0.231 |
| Fifty Day Average Change Percent | 0.2927757 |
| Fifty Two Week Change Percent | 9.278345 |
| Fifty Two Week High | 1.35 |
| Fifty Two Week High Change | -0.33000004 |
| Fifty Two Week High Change Percent | -0.24444447 |
| Fifty Two Week Low | 0.65 |
| Fifty Two Week Low Change | 0.37 |
| Fifty Two Week Low Change Percent | 0.5692308 |
| Fifty Two Week Range | 0.65 - 1.35 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,200,493,800,000 |
| Float Shares | 27,365,102 |
| Forward Eps | -0.32 |
| Forward P E | -3.1875 |
| Free Cashflow | -4,185,846 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.26097 |
| Gross Profits | 993,687 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.25531998 |
| Held Percent Institutions | 0.14962 |
| Implied Shares Outstanding | 36,438,703 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. |
| Long Name | Dyadic International, Inc. |
| Market | us_market |
| Market Cap | 37,167,476 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_4272801 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -7,291,732 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 38,625,025 |
| Number Of Analyst Opinions | 2 |
| Open | 1.06 |
| Operating Cashflow | -5,715,824 |
| Operating Margins | -1.7213 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 561 743 8333 |
| Post Market Change | -0.011600018 |
| Post Market Change Percent | -1.1372566 |
| Post Market Price | 1.0084 |
| Post Market Time | 1,783,984,094 |
| Previous Close | 1.06 |
| Price Hint | 4 |
| Price To Book | -92.72727 |
| Price To Sales Trailing12 Months | 9.761062 |
| Profit Margins | -1.91498 |
| Quick Ratio | 2.078 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.04 |
| Regular Market Change Percent | -3.77358 |
| Regular Market Day High | 1.15 |
| Regular Market Day Low | 0.98 |
| Regular Market Day Range | 0.98 - 1.15 |
| Regular Market Open | 1.06 |
| Regular Market Previous Close | 1.06 |
| Regular Market Price | 1.02 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 212,727 |
| Return On Assets | -0.56216997 |
| Return On Equity | -28.269209 |
| Revenue Growth | 1.823 |
| Revenue Per Share | 0.111 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 36,438,703 |
| Shares Percent Shares Out | 0.0047999998 |
| Shares Short | 174,705 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 622,465 |
| Short Name | Dyadic International, Inc. |
| Short Percent Of Float | 0.0057 |
| Short Ratio | 0.9 |
| Source Interval | 15 |
| State | FL |
| Symbol | DYAI |
| Target High Price | 7.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.0 |
| Target Median Price | 6.0 |
| Total Cash | 5,608,312 |
| Total Cash Per Share | 0.154 |
| Total Debt | 5,053,423 |
| Total Revenue | 3,807,729 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.21 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.89385 |
| Two Hundred Day Average Change | 0.12614995 |
| Two Hundred Day Average Change Percent | 0.141131 |
| Type Disp | Equity |
| Volume | 212,727 |
| Website | https://www.dyadic.com |
| Zip | 33,477-5094 |